

[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
Tony Butler Reiterated (BCYC) at Strong Buy and Held Target at $55 on, Feb 28th, 2023
Tony Butler of EF Hutton, Reiterated "Bicycle Therapeutics plc" (BCYC) at Strong Buy and Held Target at $55 on, Feb 28th, 2023.
Tony has made no other calls on BCYC in the last 4 months.
There are 4 other peers that have a rating on BCYC. Out of the 4 peers that are also analyzing BCYC, 0 agree with Tony's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Tony
- Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $74 on, Monday, February 27th, 2023
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $72 on, Wednesday, February 15th, 2023
- Swayampakula Ramakanth of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $57 on, Wednesday, February 15th, 2023
- Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $46 on, Wednesday, November 9th, 2022
Contributing Sources